IL146228A0 - A method of screening compounds - Google Patents

A method of screening compounds

Info

Publication number
IL146228A0
IL146228A0 IL14622800A IL14622800A IL146228A0 IL 146228 A0 IL146228 A0 IL 146228A0 IL 14622800 A IL14622800 A IL 14622800A IL 14622800 A IL14622800 A IL 14622800A IL 146228 A0 IL146228 A0 IL 146228A0
Authority
IL
Israel
Prior art keywords
compounds
screening compounds
cells
screening
melanocyte
Prior art date
Application number
IL14622800A
Other languages
English (en)
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22496233&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL146228(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ New York filed Critical Univ New York
Publication of IL146228A0 publication Critical patent/IL146228A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5035—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on sub-cellular localization
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/207—Pigmentation disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14622800A 1999-06-29 2000-06-27 A method of screening compounds IL146228A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14156399P 1999-06-29 1999-06-29
PCT/IB2000/000861 WO2001001131A1 (en) 1999-06-29 2000-06-27 Screening methods for compounds that affect melanogenesis

Publications (1)

Publication Number Publication Date
IL146228A0 true IL146228A0 (en) 2002-07-25

Family

ID=22496233

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14622800A IL146228A0 (en) 1999-06-29 2000-06-27 A method of screening compounds
IL146228A IL146228A (en) 1999-06-29 2001-10-29 An out-of-body method for filtering compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146228A IL146228A (en) 1999-06-29 2001-10-29 An out-of-body method for filtering compounds

Country Status (12)

Country Link
EP (1) EP1190248B1 (de)
JP (1) JP2003503705A (de)
KR (1) KR100823383B1 (de)
AT (1) ATE302948T1 (de)
AU (1) AU774007B2 (de)
CA (1) CA2377163A1 (de)
DE (1) DE60022193T2 (de)
HU (1) HUP0201647A3 (de)
IL (2) IL146228A0 (de)
TW (2) TW200718944A (de)
WO (1) WO2001001131A1 (de)
ZA (1) ZA200109205B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034772A1 (en) 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
US7378232B2 (en) 2002-05-09 2008-05-27 New York University Assay for melanogenesis
DE102004007032A1 (de) * 2004-02-12 2005-08-25 Beiersdorf Ag Antisense-Oligonukleotide zur Behandlung von unerwünschter Pigmentierung der Haut und der Haare
JP4819727B2 (ja) * 2007-03-19 2011-11-24 株式会社コーセー 美白成分のスクリーニング方法
WO2009064493A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Tricyclic compounds as melanogenesis modifiers and uses thereof
US8563754B2 (en) 2010-01-28 2013-10-22 New York University Compounds, compositions and methods for preventing skin darkening
WO2012103487A1 (en) 2011-01-27 2012-08-02 New York University Coumarin compounds as melanogenesis modifiers and uses thereof
JP5563710B2 (ja) * 2013-11-05 2014-07-30 株式会社ファンケル 皮膚色素沈着マーカーとその利用技術
JP7828714B2 (ja) * 2017-11-17 2026-03-12 ロート製薬株式会社 美容組成物、スクリーニング方法及び美容方法
EP3785696A1 (de) 2019-08-28 2021-03-03 B.R.A.I.N. Biotechnology Research And Information Network AG Kosmetische verwendung von aromatische formamidinderivate
WO2022238891A1 (en) * 2021-05-10 2022-11-17 Nikhil Goel Engineered cells for increased production of difficult-to-express proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292291B1 (de) * 1987-05-22 1994-08-10 University Patents, Inc. Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung
EP0507772A1 (de) * 1989-04-26 1992-10-14 Sloan-Kettering Institute For Cancer Research Nicht-melanozytische, eukaryotische zelle, die biologisch aktive menschliche tyrosinase konstitutiv exprimiert und deren verwendung
US5540914A (en) * 1989-12-15 1996-07-30 The Board Of Regents Of The University Of Oklahoma Pigmentation enhancer and method
JPH0648935A (ja) * 1992-06-02 1994-02-22 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
JP3532945B2 (ja) * 1993-11-16 2004-05-31 ポーラ化成工業株式会社 抗ヒトチロシナーゼモノクローナル抗体
JPH07324095A (ja) * 1994-05-30 1995-12-12 Hideji Itokawa 環状ペプチドシュードステラリン並びにこれを含有するチロシナーゼ活性阻害剤、メラニン生成抑制剤および皮膚化粧料

Also Published As

Publication number Publication date
IL146228A (en) 2007-07-24
HUP0201647A2 (en) 2002-08-28
TW200718944A (en) 2007-05-16
WO2001001131A1 (en) 2001-01-04
DE60022193T2 (de) 2006-06-08
ZA200109205B (en) 2003-04-30
TW200716979A (en) 2007-05-01
KR20020042541A (ko) 2002-06-05
EP1190248B1 (de) 2005-08-24
HUP0201647A3 (en) 2011-01-28
DE60022193D1 (de) 2005-09-29
KR100823383B1 (ko) 2008-04-17
EP1190248A1 (de) 2002-03-27
AU5241900A (en) 2001-01-31
CA2377163A1 (en) 2001-01-04
ATE302948T1 (de) 2005-09-15
JP2003503705A (ja) 2003-01-28
AU774007B2 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
ATE200419T1 (de) Haut- und/oder haardepigmentierungsmittel
AU1139401A (en) Cosmetic compositions containing mulberry extract and retinoids
ZA200107195B (en) Skin cosmetic composition.
PL336003A1 (en) Compositions containing santalins or santarubins intended for artificially tanning human skin
HUP9904677A3 (en) Cosmetic composition for skin care
AU7496498A (en) Skin care compositions
TWI315989B (en) Soy depigmenting and skin care compositions
ZA9810931B (en) Skin care composition with skin hydration capability.
PL329109A1 (en) Method of modulating the synthesis of melanin
AU2469197A (en) Novel cosmetic compositions for beautifying and lightening skin
WO2002098347A3 (en) Methods and compositions that affect melanogenesis (pfi-016cip/pct)
AU3573399A (en) Skin whitening composition
IL146228A0 (en) A method of screening compounds
AU2572499A (en) Human hairless gene, protein and uses thereof
ZA9810799B (en) Skin care composition
DE59904623D1 (de) Kosmetische und dermatologische zubereitungen, enthaltend erhöhte elektrolytkonzentrationen
ID24617A (id) Komposisi kosmetik yang mengkondisikan kulit
AU3270200A (en) Composition for cosmetic and dermatological skin care
DE60044633D1 (de) Nicht therapeutische Verwendung von N-acetylglucosamin zur Hautschälung
WO2002098386A3 (de) Verwendung von natriumpolystyrolsulfonat zur hautstraffung
AU2001252917A1 (en) 7 human ovarian and ovarian cancer associated proteins
ZA997520B (en) Cosmetic skin care compositions cotaining succinate compounds.
AU6787998A (en) Skin care compositions
AU2657299A (en) Skin care compositions
AU3816599A (en) Skin care cosmetic compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed